Individual Patient Compassionate Use of GX-I7
Sponsor: Genexine, Inc.
A observational or N/A phase clinical study on Advanced Cancer and Glioblastoma, this trial is ongoing. The trial is conducted by Genexine, Inc. and has accumulated 6 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
No Longer Available
-
Sep 2024 — Sep 2025 [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Apr 2022 — Jul 2024 [monthly]
No Longer Available
Status: Available → No Longer Available
-
Jan 2021 — Apr 2022 [monthly]
Available
▶ Show 1 earlier version
-
Mar 2020 — Jan 2021 [monthly]
Available
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Genexine, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .